Effect of Bromhexine Hydrochloride on patients with COVID-19

INTERVENTION: Intervention 1: Intervention group:30 patients with COVID‐19 in addition to a standard regimen will receive Bromhexine 8 mg tablets every 8 hours for 14 days from the beginning of hospitalization. Intervention 2: Control group: 30 patients will receive only standard regimen of COVID‐2019. CONDITION: Condition 1: Patients with COVID‐2019. Condition 2: . ; COVID‐19, virus identified U07.1 PRIMARY OUTCOME: Condition of discharge (death or recovery). Timepoint: End of hospitalization. Method of measurement: Observation and documents. Hospitalization days. Timepoint: At baseline and discharge time. Method of measurement: Counting the days. Need for mechanical ventilation. Timepoint: From baseline to discharge time. Method of measurement: Observation and documents. Period of mechanical ventilation. Timepoint: End of hospitalization. Method of measurement: Documents of hospitalization. INCLUSION CRITERIA: Patients with COVID‐19‐induced pneumonia confirmed with PCR Patients or authorized family members volunteered to participate in this study and signed informed consent. Both genders 18 to 80 years old